Hematology Studies and Clinical Trials

Rho has conducted 50+ hematology clinical studies and trials involving >15,000 subjects at more than 1,300 sites in over 30 countries. We have conducted industry- sponsored, government-funded, and investigator initiated research. We have a broad range of experience, including these indications:

  • Hemophilia A and B
  • von Willebrand disease
  • Sickle cell disease
  • Atypical hemolytic-uremic syndrome (aHUS)
  • Refractory hematologic malignancies
  • Chronic myelogenous leukemia
  • Progressive B-cell chronic lymphocytic leukemia
  • Acute leukemia
  • Myelodysplasia
  • Indolent non-Hodgkin’s lymphoma

Research Excellence

Rho partners with the Homeostasis and Thrombosis Research Society (HTRS) by assisting hematology fellows in the preparation of applications for the Mentored Research Awards (MRA).One of Rho’s Principal Investigators is on the editorial board of the Journal of Haemophilia and on the abstract reviewing committee for the World Federation of Hemophilia.  Our research has resulted in more than 120  publications in peer reviewed journals, including:

  • Nature
  • Lancet
  • Blood
  • Science
  • New England Journal of Medicine
  • Journal of the American Medical Association (JAMA)
  • American Journal of Hematology
  • British Journal of Haemotology
  • Journal of Thrombosis and Haemostasis
  • Haemophilia
  • Journal of Pediatric Hematology/Oncology
  • Pediatric Blood and Cancer
  • AIDS
  • Nature Medicine
  • Nature Genetics
  • Proceedings of the National Academy of Sciences
  • Pediatrics

To learn more about Rho's clinical research experience in addition to hematology, please click here.